Schedule 13D ownership disclosure
LA JOLLA PHARMACEUTICAL CO
Security class unavailable · CUSIP: 503459604
Event date: 2020-09-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,405,490
- Percent of class
- 34.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-20-007778
- Form type
- SC 13D
- Filer
- LA JOLLA PHARMACEUTICAL CO
- CIK
- CIK 920465
- Filed
- Sep 11, 2020
- Reporting period
- Sep 09, 2020
- Description
- Schedule 13D beneficial ownership